INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 45m ago
House PTR5m ago
SEC 13F4m ago
Robinhood Chain4m ago

Results

82,071 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
8
JD
Jedrzejek DavidSVP and General Counsel
LEVILEVI STRAUSS & CO
Open-market sale · 10b5-1 plan
SELL$152K
7,093 sh
Jan 27, 2026Jan 29, 2026
Page 1646 of 2052
← PrevNext →
traded Jan 27, 2026
+2d
SEC Form 4

Evidence

6
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$61K
445 sh
Jan 28, 2026Jan 29, 2026
traded Jan 28, 2026
+1dSEC Form 4

Evidence

6
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$61K
445 sh
Jan 28, 2026Jan 29, 2026
traded Jan 28, 2026
+1dSEC Form 4

Evidence

6
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$63K
455 sh
Jan 28, 2026Jan 29, 2026
traded Jan 28, 2026
+1dSEC Form 4

Evidence

6
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$63K
455 sh
Jan 28, 2026Jan 29, 2026
traded Jan 28, 2026
+1dSEC Form 4

Evidence

6
BR
Bentley Sheldon Richard10% Owner, Founder
CSAICLOUDASTRUCTURE, INC.
Open-market sale · 10b5-1 plan
SELL$21K
25.0K sh
Jan 28, 2026Jan 29, 2026
traded Jan 28, 2026
+1dSEC Form 4

Evidence

6
RR
Remer Eric RichardDirector, Chief Executive Officer
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$99K
8,268 sh
Jan 28, 2026Jan 29, 2026
traded Jan 28, 2026
+1dSEC Form 4

Evidence

6
RR
Remer Eric RichardDirector, Chief Executive Officer
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$95K
7,842 sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC Form 4

Evidence

5
TJ
Twomey Cormac JEVP, Global Ops & Delivery
CNXCConcentrix Corp
Tax withholding
F$21K
495 sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC Form 4

Evidence

5
PF
Petrie Michael F.Director, Chairman and CEO, 10% Owner
MBINMerchants Bancorp
Grant or award
A—
20.6K sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC Form 4

Evidence

3
RR
Remer Eric RichardDirector, Chief Executive Officer
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$36K
3,090 sh
Jan 29, 2026Jan 29, 2026
traded Jan 29, 2026
+0dSEC Form 4

Evidence

3
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$39K
280 sh
Jan 28, 2026Jan 29, 2026
traded Jan 28, 2026
+1dSEC Form 4

Evidence

3
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$39K
281 sh
Jan 28, 2026Jan 29, 2026
traded Jan 28, 2026
+1dSEC Form 4

Evidence

2
BR
Bentley Sheldon Richard10% Owner, Founder
CSAICLOUDASTRUCTURE, INC.
Open-market sale · 10b5-1 plan
SELL$22K
25.0K sh
Jan 27, 2026Jan 29, 2026
traded Jan 27, 2026
+2dSEC Form 4

Evidence

1
GR
Gallagher John RChief Operating Officer
TRUPTRUPANION, INC.
Open-market sale · 10b5-1 plan
SELL$14K
430 sh
Jan 28, 2026Jan 29, 2026
traded Jan 28, 2026
+1dSEC Form 4

Evidence

66
NE
Nelson Jeffrey EdwardChief Operating Officer
MISTMilestone Pharmaceuticals Inc.
Open-market sale
SELL$135K
58.0K sh
Dec 15, 2025Jan 28, 2026
traded Dec 15, 2025
+44dSEC Form 4

Evidence

62
ML
Muller LorenzChief Commercial Officer
MISTMilestone Pharmaceuticals Inc.
Open-market sale
SELL$124K
53.6K sh
Dec 15, 2025Jan 28, 2026
traded Dec 15, 2025
+44dSEC Form 4

Evidence

62
BD
Bharucha DavidChief Medical Officer
MISTMilestone Pharmaceuticals Inc.
Open-market sale
SELL$135K
58.0K sh
Dec 15, 2025Jan 28, 2026
traded Dec 15, 2025
+44dSEC Form 4

Evidence

62
HA
Hasija AmitCFO & EVP of Corp. Development
MISTMilestone Pharmaceuticals Inc.
Open-market sale
SELL$135K
58.0K sh
Dec 15, 2025Jan 28, 2026
traded Dec 15, 2025
+44dSEC Form 4

Evidence

44
SM
Stasiowska Ewa MariaChief Risk Officer
LOBLive Oak Bancshares, Inc.
Open-market purchase
BUY$100K
2,595 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

39
HE
Hutchinson Russell E.Chief Financial Officer
ALLYAlly Financial Inc.
Open-market purchase
BUY$499K
11.6K sh
Jan 27, 2026Jan 28, 2026
traded Jan 27, 2026
+1dSEC Form 4

Evidence

38
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$132K
1,238 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

38
WG
Williams GreggDirector, 10% Owner
VANIVivani Medical, Inc.
Open-market purchase
BUY$2.00M
1.35M sh
Jan 27, 2026Jan 28, 2026
traded Jan 27, 2026
+1dSEC Form 4

Evidence

38
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$78K
731 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

38
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$78K
730 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

38
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$132K
1,239 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

37
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$691K
7,007 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

37
SD
Shomaker Kelli DDirector
SMBKSMARTFINANCIAL INC.
Open-market purchase
BUY$10K
255 sh
Jan 27, 2026Jan 28, 2026
traded Jan 27, 2026
+1dSEC Form 4

Evidence

37
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$631K
6,209 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

37
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$631K
6,209 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

37
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$691K
7,007 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

36
NE
Nelson Jeffrey EdwardChief Operating Officer
MISTMilestone Pharmaceuticals Inc.
Open-market sale
SELL$24K
12.2K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

36
HA
Hasija AmitCFO & EVP of Corp. Development
MISTMilestone Pharmaceuticals Inc.
Open-market sale
SELL$24K
12.2K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

36
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$2.84M
28.8K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

36
ML
Muller LorenzChief Commercial Officer
MISTMilestone Pharmaceuticals Inc.
Open-market sale
SELL$22K
11.2K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

36
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$2.60M
25.5K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

36
BD
Bharucha DavidChief Medical Officer
MISTMilestone Pharmaceuticals Inc.
Grant or award
A—
100.0K sh
Dec 12, 2025Jan 28, 2026
traded Dec 12, 2025
+47dSEC Form 4

Evidence

36
BD
Bharucha DavidChief Medical Officer
MISTMilestone Pharmaceuticals Inc.
Open-market sale
SELL$24K
12.2K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

36
HA
Hasija AmitCFO & EVP of Corp. Development
MISTMilestone Pharmaceuticals Inc.
Grant or award
A—
100.0K sh
Dec 12, 2025Jan 28, 2026
traded Dec 12, 2025
+47dSEC Form 4

Evidence

36
ML
Muller LorenzChief Commercial Officer
MISTMilestone Pharmaceuticals Inc.
Grant or award
A—
100.0K sh
Dec 12, 2025Jan 28, 2026
traded Dec 12, 2025
+47dSEC Form 4

Evidence